Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease.
| Authors | Larry Baum, Christopher Wai Kei Lam, Stanley Kwok-Kuen Cheung, Timothy Kwok, Victor Lui, Joshua Tsoh, Linda Lam, Vivian Leung, Elsie Hui, Chelsia Ng, Jean Woo, Helen Fung Kum Chiu, William B Goggins, Benny Chung-Ying Zee, King Fai Cheng, Carmen Yuet Shim Fong, Adrian Wong, Hazel Mok, Moses Sing Sum Chow, Ping Chuen Ho, Siu Po Ip, Chung Shun Ho, Xiong Wen Yu, Caroline Yau Lin Lai, Ming-Houng Chan, Samuel Szeto, Iris Hiu Shuen Chan, Vincent Mok |
| Journal | Journal of clinical psychopharmacology
(J Clin Psychopharmacol)
Vol. 28
Issue 1
Pg. 110-3
(Feb 2008)
ISSN: 0271-0749 [Print] United States |
| PMID | 18204357
(Publication Type: Letter, Randomized Controlled Trial)
|
| Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Antioxidants
- Capsules
- Curcumin
|
| Topics |
- Aged
- Alzheimer Disease
(drug therapy)
- Anti-Inflammatory Agents, Non-Steroidal
(administration & dosage, adverse effects, therapeutic use)
- Antioxidants
(administration & dosage, therapeutic use)
- Asian People
- Capsules
- Curcuma
- Curcumin
(administration & dosage, adverse effects, therapeutic use)
- Double-Blind Method
- Female
- Hong Kong
- Humans
- Male
- Phytotherapy
- Pilot Projects
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|
